Sorry Gekko but I agree with Dazby here . You can’t let the companies funds run to low . OSL needs to do a CR in the coming months on the back of CE approval . It’s not a ideal time I know but to let the company run extremely low on cash is very dangerous . Ideally partnering with a US based company at this point would be a better option and make FDA approval that much easier . A US based company would have more clout when it comes to FDA approval and much bigger / better marketing capacity than OSL could ever hope to have . Maybe one of the Biotecs manufacturing Chemo drugs would be interested ? After all the two work as a package and if good results are achieved could dominate the market
Ann: Oncosil breakthrough device receives CE Marking approval, page-149
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $31.31M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.7¢ | $19.71K | 2.475M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 25681033 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 5068750 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |